HUTCHMED (CHINA) LIMITED revenue breakdown overview

HUTCHMED (CHINA) LIMITED revenue for the last year amounted to 6.55 B HKD, the most of which — 2.85 B HKD — came from its highest performing source at the moment, Oncology/Immunology - Research and Development, the year earlier bringing 306.97 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought HUTCHMED (CHINA) LIMITED 3.80 B HKD, and the year before that — 3.34 B HKD.